Hudson Executive Capital LP Diversified Active

CIK: 0001652522 · Show all filings

Period: Q3 2017 (← Previous) (Next →)

Filing Date: Nov 14, 2017

Total Value ($000): $198,812 (100.0% shares, 0.0% debt)

Holdings (6)

EGRX EAGLE PHARMACEUTICALS INC 29.1%

Value ($000) $57,910 Shares 971,000 Est. Cost $46.78 Unrealized +29.3%

— CIT GROUP INC 26.4%

Value ($000) $52,526 Shares 1,070,857 Est. Cost $37.71 Unrealized —

ATRC ATRICURE INC 20.9%

Value ($000) $41,496 Shares 1,855,000 Est. Cost $17.10 Unrealized +32.2%

— ACORDA THERAPEUTICS INC 10.6%

Value ($000) $21,131 Shares 893,500 Est. Cost $20.23 Unrealized —

— CORINDUS VASCULAR ROBOTICS I 8.7%

Value ($000) $17,231 Shares 11,336,154 Est. Cost $1.31 Unrealized —

— MAGELLAN HEALTH INC 4.3%

Value ($000) $8,518 Shares 98,700 Est. Cost $75.25 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
EGRX	EAGLE PHARMACEUTICALS INC	971,000	$57,910	29.1%	$46.78	+29.3%	COM	269796108
—	CIT GROUP INC	1,070,857	$52,526	26.4%	$37.71	—	COM NEW	125581801
ATRC	ATRICURE INC	1,855,000	$41,496	20.9%	$17.10	+32.2%	COM	04963C209
—	ACORDA THERAPEUTICS INC	893,500	$21,131	10.6%	$20.23	—	COM	00484M106
—	CORINDUS VASCULAR ROBOTICS I	11,336,154	$17,231	8.7%	$1.31	—	COM	218730109
—	MAGELLAN HEALTH INC	98,700	$8,518	4.3%	$75.25	—	COM NEW	559079207